Urgent Call to Action for EU Clinical Trials St...

By HEOR Staff Writer

July 28, 2025

The European Federation of Pharmaceutical Industries Associations (EFPIA) warns of Europe’s declining clinical trial opportunities. It stresses the need for the EU clinical trials strategy to tackle these issues. Since 2013, Europe has lost 60,000...
Transforming Brain Health Innovation with Patient Experience Data: Strategic ...
Dutch Pharmacoeconomic Redesign: Streamlined Structure and Enhanced Transpare...
Global Health Technology Assessment: Navigating NICE’s Role and Challen...
Model Type and Its Impact on Pneumococcal Vaccine Cost-Effectiveness in Germany
DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expan...
MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Onc...
National Bulk Purchasing Strategy: Enhancing Drug Affordability and Access in...
Elderly Care Costs 2025: Rising Financial Pressures in Dutch Health Services
Silencing Science Impact: Political Interference and Global Health Consequences
Cecolin 9 HPV Vaccine: A Game Changer for Cervical Cancer Prevention in China
Lenacapavir HIV Prevention: Gilead’s Strategic Agreement to Enhance Acc...
Revolutionizing Pediatric Care: Approval of Malaria Medicine for Newborns